Bezlotoxumab is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Bezlotoxumab is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in adult and paediatric patients 1 year of age and older at high risk for recurrence of CDI.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Bezlotoxumab is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.